He may be on kisulna for dementia [View all]

Treatment for dementia:
Administered via IV.
Possible side effect is “Difficulty walking”
another is brain bleeds, requiring FREQUENT MRIs.

Kisunla® (kih-SUHN-lah) is used to treat adults with early symptomatic Alzheimer’s disease (AD), which includes mild cognitive impairment (MCI) or mild dementia stage of disease.

Kisunla is a prescription medicine given through an intravenous (IV) infusion using a needle inserted into a vein in your arm. Kisunla is given once every 4 weeks. Each infusion will last about 30 minutes.

2.1 Patient Selection
Confirm the presence of amyloid beta pathology prior to initiating treatment

SAFETY SUMMARY WITH WARNINGS
Warnings - Kisunla can cause Amyloid-Related Imaging Abnormalities or “ARIA.” This is a common side effect that does not usually cause any symptoms, but serious symptoms can occur. ARIA can be fatal. ARIA is most commonly seen as temporary swelling in an area or areas of the brain that usually goes away over time. Some people may also have spots of bleeding on the surface of or in the brain and infrequently, larger areas of bleeding in the brain can occur. Although most people do not have symptoms, some people have:

Headache
Dizziness
Nausea
Difficulty walking
Confusion
Vision changes
Seizures

https://kisunla.lilly.com/